287193-01-5 Usage
General Description
3-Ethynyl-1-azetidinecarboxylic acid tert-butyl ester, also known as Ethynylazetidine, is a chemical compound that is used in organic synthesis and medicinal chemistry. It is commonly employed as a building block in the preparation of pharmaceuticals and bioactive molecules due to its unique structure and reactivity. 3-Ethynyl-1-azetidinecarboxylic acid tert-butyl ester is an ester derivative of a azetidine carboxylic acid, with a tert-butyl group attached to the carboxylic acid functional group. It has been studied for its potential anti-cancer and anti-inflammatory properties, and its versatile reactivity makes it a valuable tool for the preparation of diverse chemical compounds. Additionally, it has been investigated for its potential use in the synthesis of small molecule inhibitors targeting cancer and infectious diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 287193-01-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,7,1,9 and 3 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 287193-01:
(8*2)+(7*8)+(6*7)+(5*1)+(4*9)+(3*3)+(2*0)+(1*1)=165
165 % 10 = 5
So 287193-01-5 is a valid CAS Registry Number.
287193-01-5Relevant articles and documents
Compound with degrading STAT3 enzyme and preparation method and pharmaceutical application thereof
-
Paragraph 0281-0289, (2021/10/27)
The present invention relates to a compound represented by general formula (I) or a stereoisomer thereof. Use of deuterated, solvates, prodrugs, metabolites, pharmaceutically acceptable salts or co-crystals, and intermediates and preparation methods, and in STAT3-related diseases such as tumors. B-L-K(I).
SUBSTITUTED PYRAZOLO-PYRIDINE AMIDES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS
-
Page/Page column 90, (2020/12/30)
Substituted Pyrazolo-pyridines as GluN2B receptor ligands. Such compounds may be used in GluN2B receptor modulation and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by GluN2B receptor activity.
7-PHENYLETHYLAMINO-4H-PYRIMIDO[4,5-D][1,3]OXAZIN-2-ONE COMPOUNDS AND THEIT USE AS MUTANT IDH1 INHIBITORS
-
Page/Page column 42; 43, (2017/02/24)
Phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds of Formula I, formulations containing those compounds, and their use as mutant isocitrate dehydrogenase 1 enzyme inhibitors.
